Eosinophilic Asthma.
Where this comes from
- Record sourced from PubMed, PMID 31786254.
- Also identified by DOI 10.1016/j.jaip.2019.11.024.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Asthma endotypes are constantly evolving. Currently, there are no universally accepted criteria to define endotypes. The T<sub>H</sub>2-high endotype can have either allergic or nonallergic underpinnings and is typically characterized by some degree of eosinophilic airway inflammation. Unbiased clustering analyses have led to the identification of pediatric and adult phenotypes characterized by T<sub>H</sub>2 inflammation and associated endotypes with eosinophilic inflammation. Aspirin-exacerbated respiratory disease has also long been recognized as a unique asthma phenotype. An approach to identify these groups with biomarkers and subsequently choose a targeted therapeutic modality, particularly in severe disease requiring biologic agents, is outlined.
Medical subject headings
- Asthma
- Hypersensitivity
- Pulmonary Eosinophilia
- Sinusitis